comparemela.com

Latest Breaking News On - Martin caspersen - Page 2 : comparemela.com

Tetra Pharm Technologies launches first product in Germany

/PRNewswire/ Tetra Pharm Technologies develops and manufactures pharmaceutical drugs targeting the endocannabinoid system for the treatment of neuropathic.

United statesPharma einkauf gmbMartin caspersenMorten allesMartin roseTetra pharm technologiesPharm technologiesTetra pharmChief executive officerChief scientific officerEinkauf gmbhChief commercial officer

Tetra Pharm Technologies secures €9 million in Series A Round to expand R&D Operations

/PRNewswire/ The Scandinavian Biotech company, Tetra Pharm Technologies has secured €9M in a series A round led by a group of Danish investors. The company,.

Martin roseMorten allesMartin caspersenNesroht holdingOle gs holdingScandinavian biotechTetra pharm technologiesTetra pharmLeafy tunnelRump invest

Tetra Pharm Technologies closes a €2 million Seed Round to expand its operations and initiate clinical trials

COPENHAGEN, Denmark, Dec. 15, 2021 Tetra Pharm Technologies, a Danish Biotech company, secured €2M in its first round of funding led by Leafy Tunnel, .

Nikolay tretiyakovMartin roseJesper breumMartin caspersenTetra pharm technologies coPharm technologiesDanish biotechLeafy tunnelTetra pharmMedicon valleyBek muslimovFounding partnersProhibition partnersPharm technologies co founder

Tetra Pharm Technologies closes a €2 million Seed Round to expand its operations and initiate clinical trials

Tetra Pharm Technologies closes a €2 million Seed Round to expand its operations and initiate clinical trials PR Newswire COPENHAGEN, Denmark, Dec. 15, 2021 COPENHAGEN, Denmark

Nikolay tretiyakovMartin roseKostenloser wertpapierhandelJesper breumMartin caspersenTetra pharm technologies coTetra pharm technologiesSeed roundPharm technologiesDanish biotechLeafy tunnelTetra pharmMedicon valleyBek muslimovFounding partnersProhibition partners

Tetra Pharm Technologies closes a €2 million Seed Round to expand its operations and initiate clinical trials

COPENHAGEN, Denmark, Dec. 15, 2021 Tetra Pharm Technologies, a Danish Biotech company, secured €2M in its first round of funding led by Leafy Tunnel, a.

Nikolay tretiyakovMartin roseJesper breumMartin caspersenTetra pharm technologies coPharm technologiesDanish biotechLeafy tunnelTetra pharmMedicon valleyBek muslimovFounding partnersProhibition partnersPharm technologies co founderTetra pharm technologies

vimarsana © 2020. All Rights Reserved.